Otherwise, TRFE, TTHY and HEMO were found to be closely associated with inflammation and BPH rather than cancer, and therefore, they are unlikely candidate biomarkers for PCa. This evidence concerns the gene ERVMER34-1 and benign prostatic hyperplasia.